2024 Critical Care Congress Skip to main content
2024 Critical Care Congress Main banner
Back

Paritosh Prasad, BA, BS, MBA, MD

Associate Professor of Medicine, Pediatrics and Surgery
University of Rochester Medical Center
Rochester

I am a quadruple board certified physician boarded in Internal Medicine, Pediatrics, Infectious Disease and Critical Care with sub-specialty fellowship training in Transplant and Immunocompromised Infectious Disease as well as a Diploma in Tropical Medicine and Hygiene. I now serve as Director of Surgical Critical Care, Director of Transplant and Immunocompromised Infectious Disease, and Director of the Highly Infectious Disease Units at the University of Rochester Medical Center. My clinical activities include practice as an intensive care physician in the Surgical ICU where we care for complex and critically ill perioperative and post-operative patients as well as critically ill patients with cirrhosis and consultation as a Transplant Infectious Disease physician caring for the infectious complications of solid organ transplant, bone marrow transplant and in the setting of liquid tumors. I have interests in clinical education and oversee the Transplant Infectious Disease Fellowship and coordinate the Critical Care Lecture curriculum for Internal Medicine, Emergency Medicine, Anesthesia and Surgical Residents as well as 3rd and 4th year Medical Students on ICU rotations at URMC. My research efforts focus on questions pertaining to optimized clinical care and quality improvement across Infectious Disease and Critical Care and highlights of my efforts include assessing the use of patient monitoring systems to expand access to operative therapies that reduced use of critical care resources, hospital length of stay and systemic opiate exposure, exploring low technology efforts to reduce Clostridium difficile infection, studying the real-world implications of diagnostic tests like the serum galactomannan assay and the real world efficacy of broad-spectrum antibiotics like Tigecycline. Finally, during the course of the COVID Pandemic, I served as Director of the Highly Infectious Disease Units at URMC and have a focused expertise in COVID diagnosis and management and use of the evolving armamentarium of anti-SARS-CoV-2 therapeutics (antivirals, monoclonal antibodies, etc).

Presentation(s):

Email Paritosh